Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

High Progression Free Survival Rates in Patients with Multiply Relapsed/Refractory Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplant after Checkpoint Inhibitors: Results from Grupo Argentino De Trasplante De Medula Osea y Terapia Celular (GATMO-TC)

Blood (2023) 142 (Supplement 1): 2220.

https://doi.org/10.1182/blood-2023-182331

Published: 2023

Journal Articles

Microenvironment Immune Cells in Bone Marrow and Lymph Node Measured By Flow Cytometry Have Prognostic Impact on Survival in Nodal Non-Hodgkin T-Cell Lymphoma

Laura Korin, Maria Lucia Fuente, Santiago Cranco, Paola Ochoa, Adriana Vitriu, Evelina Babuin, Olivia Gelo, Luis Ayala, Paula Tempra, Andrea Novoa, Maria Belen Venegas, Anahí Vijnovich Baron, Maria Del Rosario Custidiano, Norma Elisabeth Tartas, Maria Cecilia Foncuberta, Julio Cesar Sanchez Avalos

Blood (2022) 140 (Supplement 1): 11936–11937.

https://doi.org/10.1182/blood-2022-167240

Published: 2022

Journal Articles

Low Percentage of Microenvironment Immune Cells in Bone Marrow and Lymph Node Measured By Flow Cytometry Is Associated with Inferior Overall Survival in Diffuse Large B Cell Lymphoma

Laura Korin, Maria Lucia Fuente, Santiago Cranco, Paola Ochoa, Adriana Vitriu, Evelina Babuin, Anahí Vijnovich Baron, Maria Belen Venegas, Paula Tempra, Andrea Novoa, Norma Elisabeth Tartas, Maria Del Rosario Custidiano, Maria Cecilia Foncuberta, Julio Cesar Sanchez Avalos

Blood (2021) 138 (Supplement 1): 2415.

https://doi.org/10.1182/blood-2021-150839

Published: 2021

Journal Articles

Bone Marrow Microenvironment Immune Cells Measured By Flow Cytometry Can Predict Survival and Identify a Subgroup in Risk of Early Relapse in Diffuse Large B Cell Lymphoma Patients

Laura Korin, MD, Santiago Cranco, MD, Maria Lucia Fuente, Paola Ochoa, MD, Adriana Vitriu, MD, Evelina Babuin, Maria Belen Venegas, Paula Tempra, Andrea Novoa, Anahí Vijnovich Baron, MD, Fernando Diaz Couselo, MD, Norma Elisabeth Tartas, MD, Maria Del Rosario Custidiano, MD, Maria Cecilia Foncuberta, MD, Julio Cesar Sanchez Avalos, MD

Blood (2020) 136 (Supplement 1): 23.

https://doi.org/10.1182/blood-2020-138881

Published: 2020

Journal Articles

In Pursuit of Surrogate Markers for Treatment-Free Remission in Patients with Chronic Myeloid Leukemia from Argentina Stop Trial

Blood (2020) 136 (Supplement 1): 24.

https://doi.org/10.1182/blood-2020-141067

Published: 2020

Journal Articles

Percentage of Infiltrating T Lymphocytes in Diffuse Large B-Cell Lymphoma Lymph Nodes Measured By Flow Cytometry Predicts Overall Survival and Provides Additional Prognostic Information When Combined with the R-IPI

Laura Korin, MD, Maria Del Rosario Custidiano, MD, Maria Lucia Fuente, Santiago Cranco, MD, Adriana Vitriu, MD, Paola Ochoa, MD, Evelina Babuin, Fernando Diaz Couselo, MD, Anahí Vijnovich Baron, MD, Paula Tempra, Maria Belen Venegas, Andrea Novoa, Norma Elisabeth Tartas, MD, Maria Cecilia Foncuberta, MD, Julio Cesar Sanchez Avalos, MD

Blood (2019) 134 (Supplement_1): 1625.

https://doi.org/10.1182/blood-2019-126193

Published: 2019

Journal Articles

Outcomes of First-Line Treatment (FL) of Classical Hodgkin Lymphoma (cHL) in Argentina: A Real Life Multicenter Retrospective Study

Blood (2019) 134 (Supplement_1): 4046.

https://doi.org/10.1182/blood-2019-126314

Published: 2019

Journal Articles

Induction Treatment and Feasibility of Allogeneic Hematopoietic Stem Cell Transplantation in Young Patients (<65 years) with High-Risk Cytogenetic and Secondary Acute Myeloid Leukemia (AML): A Single Center Experience in Argentina with CLAG-M and 7+3

Maria Lucia Fuente, Maria Del Rosario Custidiano, MD, Santiago Cranco, MD, Laura Korin, MD, Paola Ochoa, MD, Adriana Vitriu, MD, Evelina Babuin, Andrea Novoa, Paula Tempra, Maria Belen Venegas, Fernando Diaz Couselo, MD, Norma Elisabeth Tartas, MD, Julio Cesar Sanchez Avalos, MD, Maria Cecilia Foncuberta, MD

Blood (2019) 134 (Supplement_1): 5132.

https://doi.org/10.1182/blood-2019-128491

Published: 2019

Journal Articles

Comparison of Outcomes after Matched Sibling, Unrelated, or Haploidentical Allogeneic Hematopoietic Cell Transplantations (HCT). a Real World Experience of Gatmo (Grupo Argentino de Trasplante de Médula Ósea)

Jose Ignacio Ignacio Trucco, Mariano Berro, MD, Maria Marta Rivas, MD, Pablo Gabriel Longo, MD, Juan Jose Garcia, MD, Pablo Andres Garcia, MD, Ana Basquiera, MD, Gonzalo Ariel Ferini, MD, Sebastian Yantorno, MD, Jorge Milone, MD, Silvina Palmer, MD, German Stemmelin, MD, Alejandro Requejo, MD, Gregorio Jaimovich, MD, Adriana Vitriu, MD, Maria Cecilia Foncuberta, MD, Juliana Martinez Rolon, MD, Gustavo Kusminsky, MD

Blood (2017) 130 (Supplement 1): 2054.

https://doi.org/10.1182/blood.V130.Suppl_1.2054.2054

Published: 2017

Journal Articles

Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Argentina: Results Comparing Matched Related, Unrelated or Haploidentical Donors. a Grupo Argentino De Trasplante De Medula Osea (GATMO) Experience

Jose Ignacio Ignacio Trucco, Mariano Berro, MD, Maria Marta Rivas, MD, Pablo Gabriel Longo, MD, Pablo Andres Garcia, MD, Juan Jose Garcia, MD, Ana Basquiera, MD, Gonzalo Ariel Ferini, MD, Sebastian Yantorno, MD, Jorge Milone, MD, Silvina Palmer, MD, German Stemmelin, MD, Alejandro Requejo, MD, Gregorio Jaimovich, MD, Adriana Vitriu, MD, Maria Cecilia Foncuberta, MD, Juliana Martinez Rolon, MD, Gustavo Kusminsky, MD

Blood (2017) 130 (Supplement 1): 5558.

https://doi.org/10.1182/blood.V130.Suppl_1.5558.5558

Published: 2017

Journal Articles

A Retrospective Multicenter Analysis of the Safety and Efficacy of Brentuximab Vedotin (BV) As Monotherapy or in Combination with Bendamustine (BV-B) in Relapsed Refractory Classic Hodgkin Lymphoma (cHL) in Argentina

Florencia Negri Aranguren, MD, Santiago Cranco, Claudia Shanley, MD, Isolda I. Fernandez, MD, Maria Virginia Prates, MD, Victoria Otero, Lorena Fiad, Maria Cecilia Foncuberta, MD, Marcela Miodosky, MD, Miguel A. Pavlovsky, MD, Gustavo Kuminsky, Javier Bordone, Bruno Wannesson, Ariel Corso Corso, Dardo Riveros, MD, Marisa Marquez, MD, Gustavo Jarchum, MD, Maria Sol Jarchum, Ider Ramon Cerutti, MD, Alicia Bistmas, Monica Tamashiro, MD, Giselda De Stefano, Alicia Navieckas, Silvana Cugliari, MD, Pedro Negri Aranguren, MD, Gabriela Balaguer, Maria Tosin, Guillermina Remaggi, Juan Altuve, Juan Jose Garcia, MD, Luciana C. Ferrari, MD, Graciela Klein, Luciana Guanchiale, Luis Beligoy, MD, Mariana Marull, Maria Cecilia Dacunto, Marta Elisa Zerga, MD, Nicolas Matias Kurgansky, MD, Marcelo Pujol, MD, Rossana L. Taus, MD PhD, Federico Sackman, MD PhD, Veronica Cintia Canosa, Soledad Cruset, Maximiliano Riddick, Astrid Pavlovsky, MD

Blood (2017) 130 (Supplement 1): 4089.

https://doi.org/10.1182/blood.V130.Suppl_1.4089.4089

Published: 2017

Journal Articles

HCT.CI in Autologous Stem Cell Transplantation. Predicting Early and Late Transplant Related Mortality

Blood (2016) 128 (22): 3449.

https://doi.org/10.1182/blood.V128.22.3449.3449

Published: 2016

Journal Articles

TGFB1 Functional Polymorphisms in Sibling HSCT. "Tto be or Not Tto be"

Mariano Berro, MD, Virginia Palau, Maria Marta Rivas, MD, Maria Cecilia Foncuberta, MD, Adriana Vitriu, MD, Guillermina Remaggi, MD, Gregorio Jaimovich, MD, Alejandro Requejo, MD, Juliana Martinez Rolon, MD, Irene Larripa, PhD, Karin Padros, Maria Beatriz Rodriguez, Carolina Barbara Belli, PhD, Gustavo Daniel Kusminsky, MD, Leonardo J Feldman, MD

Blood (2015) 126 (23): 4275.

https://doi.org/10.1182/blood.V126.23.4275.4275

Published: 2015

Journal Articles

TGFB1 Functional Polymorphisms: Impact on Outcome in Allogeneic Sibling Donor Haematopoietic Stem Cell Transplantation

Mariano Berro, MD, Virginia Palau, Maria Marta Rivas, MD, Juliana Martinez Rolon, MD, Adriana Vitriu, MD, Karin Padros, Guillermina Remaggi, PhD, Maria Cecilia Foncuberta, MD, Maria Beatriz Rodriguez, Carolina Belli, PhD, Irene B Larripa, PhD, Gustavo Daniel Kusminsky, MD

Blood (2014) 124 (21): 3806.

https://doi.org/10.1182/blood.V124.21.3806.3806

Published: 2014

Journal Articles

Is Not Age, But Comorbidities. Allogeneic Hematopoietic Stem Cell Transplantation In Patients Older Than 50 Years In Argentina

Mariano Berro, MD, Juan Garcia, MD, Ana Basquiera, MD, Maria Marta Rivas, MD, Maria Cecilia Foncuberta, MD, Ruben Burgos, MD, Gregorio Jaimovich, Vera Milovic, Juliana Martinez Rolon, MD, Guillermina Remaggi, PhD, Jorge Arbelbide, MD, Jorge H Milone, Sebastian Yantorno, Gustavo Jarchum, MD, Maria Sol Jarchum, G Caeiro, Gustavo Daniel Kusminsky, MD

Blood (2013) 122 (21): 5467.

https://doi.org/10.1182/blood.V122.21.5467.5467

Published: 2013

Journal Articles

Allogeneic Stem Cell Transplantation With Reduced Intensity Conditioning Regimen In Patients With Relapsed Hodgkin´s Lymphoma

Maria Marta Rivas, MD, Mariano Berro, MD, Sebastian Yantorno, MD, Maria Virginia Prates, MD, Jorge H Milone, Ana Lisa Basquiera, Adriana Berreta, MD, Juan Garcia, MD, Guillermina Remaggi, MD, Juliana Martinez Rolon, MD, Jorge Arbelbide, MD, Monica Makiya, MD, Eduardo Dibar, Alejandro Requejo, MD, Leonardo Julio Feldman, Sr., MD, Vera Milovic, Maria Cecilia Foncuberta, MD, Rubén Burgos, MD, Gustavo Daniel Kusminsky, MD

Blood (2013) 122 (21): 5511.

https://doi.org/10.1182/blood.V122.21.5511.5511

Published: 2013

Journal Articles

A Phase 2 Study of 90 Y-Ibritumomab Tiuxetan ( 90 Y-Zevalin®) in Relapsed/Refractory Non-Hodgkin’s Lymphoma: Preliminary Report of the Argentinean Cooperative Group.

Roberto E. Cacchione, MD, Jorge Milone, Javier Bordone, Juan Dupont, Gustavo Milone, Dardo Riveros, Pedro Negri, María Ardaiz, Leandro Riera, Maria Cecilia Foncuberta, Fernando Bezares

Blood (2006) 108 (11): 4688.

https://doi.org/10.1182/blood.V108.11.4688.4688

Published: 2006

NARROW

High Progression Free Survival Rates in Patients with Multiply Relapsed/Refractory Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplant after Checkpoint Inhibitors: Results from Grupo Argentino De Trasplante De Medula Osea y Terapia Celular (GATMO-TC)

Microenvironment Immune Cells in Bone Marrow and Lymph Node Measured By Flow Cytometry Have Prognostic Impact on Survival in Nodal Non-Hodgkin T-Cell Lymphoma

Low Percentage of Microenvironment Immune Cells in Bone Marrow and Lymph Node Measured By Flow Cytometry Is Associated with Inferior Overall Survival in Diffuse Large B Cell Lymphoma

Bone Marrow Microenvironment Immune Cells Measured By Flow Cytometry Can Predict Survival and Identify a Subgroup in Risk of Early Relapse in Diffuse Large B Cell Lymphoma Patients

In Pursuit of Surrogate Markers for Treatment-Free Remission in Patients with Chronic Myeloid Leukemia from Argentina Stop Trial

Percentage of Infiltrating T Lymphocytes in Diffuse Large B-Cell Lymphoma Lymph Nodes Measured By Flow Cytometry Predicts Overall Survival and Provides Additional Prognostic Information When Combined with the R-IPI

Outcomes of First-Line Treatment (FL) of Classical Hodgkin Lymphoma (cHL) in Argentina: A Real Life Multicenter Retrospective Study

Induction Treatment and Feasibility of Allogeneic Hematopoietic Stem Cell Transplantation in Young Patients (<65 years) with High-Risk Cytogenetic and Secondary Acute Myeloid Leukemia (AML): A Single Center Experience in Argentina with CLAG-M and 7+3

Comparison of Outcomes after Matched Sibling, Unrelated, or Haploidentical Allogeneic Hematopoietic Cell Transplantations (HCT). a Real World Experience of Gatmo (Grupo Argentino de Trasplante de Médula Ósea)

Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Argentina: Results Comparing Matched Related, Unrelated or Haploidentical Donors. a Grupo Argentino De Trasplante De Medula Osea (GATMO) Experience

A Retrospective Multicenter Analysis of the Safety and Efficacy of Brentuximab Vedotin (BV) As Monotherapy or in Combination with Bendamustine (BV-B) in Relapsed Refractory Classic Hodgkin Lymphoma (cHL) in Argentina

HCT.CI in Autologous Stem Cell Transplantation. Predicting Early and Late Transplant Related Mortality

TGFB1 Functional Polymorphisms in Sibling HSCT. "Tto be or Not Tto be"

TGFB1 Functional Polymorphisms: Impact on Outcome in Allogeneic Sibling Donor Haematopoietic Stem Cell Transplantation

Is Not Age, But Comorbidities. Allogeneic Hematopoietic Stem Cell Transplantation In Patients Older Than 50 Years In Argentina

Allogeneic Stem Cell Transplantation With Reduced Intensity Conditioning Regimen In Patients With Relapsed Hodgkin´s Lymphoma

A Phase 2 Study of 90 Y-Ibritumomab Tiuxetan ( 90 Y-Zevalin®) in Relapsed/Refractory Non-Hodgkin’s Lymphoma: Preliminary Report of the Argentinean Cooperative Group.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only